283 related articles for article (PubMed ID: 31014368)
21. Inhibition of p38 MAPK activity leads to cell type-specific effects on the molecular circadian clock and time-dependent reduction of glioma cell invasiveness.
Goldsmith CS; Kim SM; Karunarathna N; Neuendorff N; Toussaint LG; Earnest DJ; Bell-Pedersen D
BMC Cancer; 2018 Jan; 18(1):43. PubMed ID: 29316898
[TBL] [Abstract][Full Text] [Related]
22. Systems Level Understanding of Circadian Integration with Cell Physiology.
Morris AR; Stanton DL; Roman D; Liu AC
J Mol Biol; 2020 May; 432(12):3547-3564. PubMed ID: 32061938
[TBL] [Abstract][Full Text] [Related]
23. A novel signature derived from immunoregulatory and hypoxia genes predicts prognosis in liver and five other cancers.
Chang WH; Forde D; Lai AG
J Transl Med; 2019 Jan; 17(1):14. PubMed ID: 30626396
[TBL] [Abstract][Full Text] [Related]
24. Circadian clock and cell cycle: Cancer and chronotherapy.
Yao J; He C; Zhao W; Hu N; Long D
Acta Histochem; 2021 Dec; 123(8):151816. PubMed ID: 34800857
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Nuclear Magnetic Resonance affects the core clock mechanism and associated Hypoxia-inducible factor-1.
Thöni V; Oliva R; Mauracher D; Egg M
Chronobiol Int; 2021 Aug; 38(8):1120-1134. PubMed ID: 33847185
[TBL] [Abstract][Full Text] [Related]
26. The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy.
Ye Y; Xiang Y; Ozguc FM; Kim Y; Liu CJ; Park PK; Hu Q; Diao L; Lou Y; Lin C; Guo AY; Zhou B; Wang L; Chen Z; Takahashi JS; Mills GB; Yoo SH; Han L
Cell Syst; 2018 Mar; 6(3):314-328.e2. PubMed ID: 29525205
[TBL] [Abstract][Full Text] [Related]
27. Metabolic rivalry: circadian homeostasis and tumorigenesis.
Kinouchi K; Sassone-Corsi P
Nat Rev Cancer; 2020 Nov; 20(11):645-661. PubMed ID: 32895495
[TBL] [Abstract][Full Text] [Related]
28. Circadian Oscillations Persist in Cervical and Esophageal Cancer Cells Displaying Decreased Expression of Tumor-Suppressing Circadian Clock Genes.
van der Watt PJ; Roden LC; Davis KT; Parker MI; Leaner VD
Mol Cancer Res; 2020 Sep; 18(9):1340-1353. PubMed ID: 32503923
[TBL] [Abstract][Full Text] [Related]
29. Cancer clocks in tumourigenesis: the p53 pathway and beyond.
Stephenson EM; Usselmann LEJ; Tergaonkar V; Virshup DM; Dallmann R
Endocr Relat Cancer; 2021 Apr; 28(4):R95-R110. PubMed ID: 33638942
[TBL] [Abstract][Full Text] [Related]
30. It's About Time: Advances in Understanding the Circadian Regulation of DNA Damage and Repair in Carcinogenesis and Cancer Treatment Outcomes.
Ashok Kumar PV; Dakup PP; Sarkar S; Modasia JB; Motzner MS; Gaddameedhi S
Yale J Biol Med; 2019 Jun; 92(2):305-316. PubMed ID: 31249491
[TBL] [Abstract][Full Text] [Related]
31. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract][Full Text] [Related]
32. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
[TBL] [Abstract][Full Text] [Related]
33. Circadian Clock Genes Modulate Immune, Cell Cycle and Apoptosis in the Diagnosis and Prognosis of Pan-Renal Cell Carcinoma.
Liu S; Cheng Y; Wang S; Liu H
Front Mol Biosci; 2021; 8():747629. PubMed ID: 34977153
[No Abstract] [Full Text] [Related]
34. The Circadian Clock Gene, Bmal1, Regulates Intestinal Stem Cell Signaling and Represses Tumor Initiation.
Stokes K; Nunes M; Trombley C; Flôres DEFL; Wu G; Taleb Z; Alkhateeb A; Banskota S; Harris C; Love OP; Khan WI; Rueda L; Hogenesch JB; Karpowicz P
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1847-1872.e0. PubMed ID: 34534703
[TBL] [Abstract][Full Text] [Related]
35. The circadian clock is disrupted in pancreatic cancer.
Schwartz PB; Nukaya M; Berres ME; Rubinstein CD; Wu G; Hogenesch JB; Bradfield CA; Ronnekleiv-Kelly SM
PLoS Genet; 2023 Jun; 19(6):e1010770. PubMed ID: 37262074
[TBL] [Abstract][Full Text] [Related]
36. The circadian clock in cancer development and therapy.
Fu L; Kettner NM
Prog Mol Biol Transl Sci; 2013; 119():221-82. PubMed ID: 23899600
[TBL] [Abstract][Full Text] [Related]
37. Circadian clock associates with tumor microenvironment in thoracic cancers.
Yang Y; Yuan G; Xie H; Wei T; Zhu D; Cui J; Liu X; Shen R; Zhu Y; Yang X
Aging (Albany NY); 2019 Dec; 11(24):11814-11828. PubMed ID: 31881010
[TBL] [Abstract][Full Text] [Related]
38. Dual prognostic role of 2-oxoglutarate-dependent oxygenases in ten cancer types: implications for cell cycle regulation and cell adhesion maintenance.
Chang WH; Forde D; Lai AG
Cancer Commun (Lond); 2019 Apr; 39(1):23. PubMed ID: 31036064
[TBL] [Abstract][Full Text] [Related]
39. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
Front Immunol; 2022; 13():891175. PubMed ID: 35990668
[TBL] [Abstract][Full Text] [Related]
40. The panoramic picture of pepsinogen gene family with pan-cancer.
Shen S; Li H; Liu J; Sun L; Yuan Y
Cancer Med; 2020 Dec; 9(23):9064-9080. PubMed ID: 33067881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
